Molinari Francesco, Fink Christian, Risse Frank, Tuengerthal Siegfried, Bonomo Lorenzo, Kauczor Hans-Ulrich
Department of Radiological Sciences, Catholic University of Rome, Rome, Italy.
Invest Radiol. 2006 Aug;41(8):624-30. doi: 10.1097/01.rli.0000225399.65609.45.
We sought to assess the agreement between lung perfusion ratios calculated from pulmonary perfusion magnetic resonance imaging (MRI) and those calculated from radionuclide (RN) perfusion scintigraphy.
A retrospective analysis of MR and RN perfusion scans was conducted in 23 patients (mean age, 60 +/- 14 years) with different lung diseases (lung cancer = 15, chronic obstructive pulmonary disease = 4, cystic fibrosis = 2, and mesothelioma = 2). Pulmonary perfusion was assessed by a time-resolved contrast-enhanced 3D gradient-echo pulse sequence using parallel imaging and view sharing (TR = 1.9 milliseconds; TE = 0.8 milliseconds; parallel imaging acceleration factor = 2; partition thickness = 4 mm; matrix = 256 x 96; in-plane spatial resolution = 1.87 x 3.75 mm; scan time for each 3D dataset = 1.5 seconds), using gadolinium-based contrast agents (injection flow rate = 5 mL/s, dose = 0.1 mmol/kg of body weight). The peak concentration (PC) of the contrast agent bolus, the pulmonary blood flow (PBF), and blood volume (PBV) were computed from the signal-time curves of the lung. Left-to-right ratios of pulmonary perfusion were calculated from the MR parameters and RN counts. The agreement between these ratios was assessed for side prevalence (sign test) and quantitatively (Deming-regression).
MR and RN ratios agreed on side prevalence in 21 patients (91%) with PC, in 20 (87%) with PBF, and in 17 (74%) with PBV. The MR estimations of left-to-right perfusion ratios correlated significantly with those of RN perfusion scans (P < 0.01). The correlation was higher using PC (r = 0.67) and PBF (r = 0.66) than using PBV (r = 0.50). The MR ratios computed from PBF showed the highest accuracy, followed by those from PC and PBV. Independently from the MR parameter used, in some patients the quantitative difference between the MR and RN ratios was not negligible.
Pulmonary perfusion MRI can be used to assess the differential blood flow of the lung. Further studies in a larger group of patients are required to fully confirm the clinical suitability of this imaging method.
我们试图评估通过肺灌注磁共振成像(MRI)计算得出的肺灌注比率与通过放射性核素(RN)灌注闪烁扫描计算得出的肺灌注比率之间的一致性。
对23例(平均年龄60±14岁)患有不同肺部疾病(肺癌15例、慢性阻塞性肺疾病4例、囊性纤维化2例、间皮瘤2例)的患者进行了MR和RN灌注扫描的回顾性分析。采用时间分辨对比增强三维梯度回波脉冲序列,利用并行成像和视图共享技术评估肺灌注(重复时间(TR)=1.9毫秒;回波时间(TE)=0.8毫秒;并行成像加速因子=2;层厚=4毫米;矩阵=256×96;平面内空间分辨率=1.87×3.75毫米;每个三维数据集扫描时间=1.5秒),使用基于钆的对比剂(注射流速=5毫升/秒,剂量=0.1毫摩尔/千克体重)。从肺的信号-时间曲线计算对比剂团注的峰值浓度(PC)、肺血流量(PBF)和血容量(PBV)。根据MR参数和RN计数计算肺灌注的左右比率。通过侧别患病率(符号检验)和定量方法(戴明回归)评估这些比率之间的一致性。
MR和RN比率在21例(91%)患者的PC、20例(87%)患者的PBF和17例(74%)患者的PBV的侧别患病率上达成一致。MR对左右灌注比率的估计与RN灌注扫描的估计显著相关(P<0.01)。使用PC(r=0.67)和PBF(r=0.66)时的相关性高于使用PBV(r=0.50)时。由PBF计算得出的MR比率显示出最高的准确性,其次是由PC和PBV计算得出的比率。无论使用何种MR参数,在一些患者中,MR和RN比率之间的定量差异都不可忽略。
肺灌注MRI可用于评估肺的差异血流。需要在更大规模的患者群体中进行进一步研究,以充分证实这种成像方法的临床适用性。